PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL (2002) Nat Med 8: 1145-52 Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells. Van Dross R, Yao S, Asad S, Westlake G, Mays DJ, Barquero L, Duell S, Pietenpol JA, Browning PJ (2005) J Natl Cancer Inst 97: 656-66 Phosphatidylinositol 3-kinase signaling determines kidney size. Chen JK, Nagai K, Chen J, Plieth D, Hino M, Xu J, Sha F, Ikizler TA, Quarles CC, Threadgill DW, Neilson EG, Harris RC (2015) J Clin Invest 125: 2429-44 Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function. Muraoka RS, Lenferink AE, Simpson J, Brantley DM, Roebuck LR, Yakes FM, Arteaga CL (2001) J Cell Biol 153: 917-32 Comparison of the effects of recombinant adenovirus-mediated expression of wild-type p53 and p27Kip1 on cell cycle and apoptosis in SUDHL-1 cells derived from anaplastic large cell lymphoma. Turturro F, Frist AY, Arnold MD, Pal A, Cook GA, Seth P (2001) Leukemia 15: 1225-31 Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis. Keller UB, Old JB, Dorsey FC, Nilsson JA, Nilsson L, MacLean KH, Chung L, Yang C, Spruck C, Boyd K, Reed SI, Cleveland JL (2007) EMBO J 26: 2562-74 Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL (2000) Proc Natl Acad Sci U S A 97: 9609-14 RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM (2009) Proc Natl Acad Sci U S A 106: 9268-73 ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. Lenferink AE, Busse D, Flanagan WM, Yakes FM, Arteaga CL (2001) Cancer Res 61: 6583-91 Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Wu FY, Wang SE, Sanders ME, Shin I, Rojo F, Baselga J, Arteaga CL (2006) Cancer Res 66: 2162-72 Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action. Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S, Arteaga CL (2002) Cancer Res 62: 4132-41 Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice. Zeng F, Miyazawa T, Kloepfer LA, Harris RC (2014) Kidney Int 86: 538-47 PPAR-gamma agonist protects podocytes from injury. Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB (2007) Kidney Int 71: 1232-9 Cdk inhibitor p27Kip1 and hormone dependence in breast cancer. Arteaga CL (2004) Clin Cancer Res 10: 368S-71S Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers. Song W, Hwang Y, Youngblood VM, Cook RS, Balko JM, Chen J, Brantley-Sieders DM (2017) Oncogene 36: 5620-5630 Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1). Turturro F, Frist AY, Arnold MD, Seth P, Pulford K (2001) Oncogene 20: 4466-75 Genetic rescue of cell number in a mouse model of microphthalmia: interactions between Chx10 and G1-phase cell cycle regulators. Green ES, Stubbs JL, Levine EM (2003) Development 130: 539-52 Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Law BK, Chytil A, Dumont N, Hamilton EG, Waltner-Law ME, Aakre ME, Covington C, Moses HL (2002) Mol Cell Biol 22: 8184-98 Renal oxygenation suppresses VHL loss-induced senescence that is caused by increased sensitivity to oxidative stress. Welford SM, Dorie MJ, Li X, Haase VH, Giaccia AJ (2010) Mol Cell Biol 30: 4595-603 Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27. Mack FA, Patel JH, Biju MP, Haase VH, Simon MC (2005) Mol Cell Biol 25: 4565-78 ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Muraoka RS, Lenferink AE, Law B, Hamilton E, Brantley DM, Roebuck LR, Arteaga CL (2002) Mol Cell Biol 22: 2204-19 Prognostic role of p27Kip1 and apoptosis in human breast cancer. Wu J, Shen ZZ, Lu JS, Jiang M, Han QX, Fontana JA, Barsky SH, Shao ZM (1999) Br J Cancer 79: 1572-8 Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women. Cai H, Xiang YB, Qu S, Long J, Cai Q, Gao J, Zheng W, Shu XO (2011) Am J Epidemiol 173: 1263-71 Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry. Shin I, Rotty J, Wu FY, Arteaga CL (2005) J Biol Chem 280: 6055-63 Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity. Busse D, Doughty RS, Ramsey TT, Russell WE, Price JO, Flanagan WM, Shawver LK, Arteaga CL (2000) J Biol Chem 275: 6987-95 Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise. Azzoli CG, Park BJ, Pao W, Zakowski M, Kris MG (2008) J Thorac Oncol 3: 84-93 HER-2/neu (erbB-2) and the cell cycle. Busse D, Doughty RS, Arteaga CL (2000) Semin Oncol 27: 3-8; discussion 92-100 p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Levine EM, Close J, Fero M, Ostrovsky A, Reh TA (2000) Dev Biol 219: 299-314 The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit. Cunningham JJ, Levine EM, Zindy F, Goloubeva O, Roussel MF, Smeyne RJ (2002) Mol Cell Neurosci 19: 359-74 Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Ohmori T, Yang JL, Price JO, Arteaga CL (1998) Exp Cell Res 245: 350-9 Cyclin D1 fine-tunes the neurogenic output of embryonic retinal progenitor cells. Das G, Choi Y, Sicinski P, Levine EM (2009) Neural Dev 4: 15 c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. Alexandrow MG, Moses HL (1998) J Cell Biochem 70: 528-42 c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor. Chandramohan V, Mineva ND, Burke B, Jeay S, Wu M, Shen J, Yang W, Hann SR, Sonenshein GE (2008) J Cell Biochem 104: 2091-106 Differential regulation of cyclin-dependent kinase inhibitors in neuroblastoma cells. Qiao L, Paul P, Lee S, Qiao J, Wang Y, Chung DH (2013) Biochem Biophys Res Commun 435: 295-9 Defects in retinal pigment epithelium cell proliferation and retinal attachment in mutant mice with p27(Kip1) gene ablation. Defoe DM, Adams LB, Sun J, Wisecarver SN, Levine EM (2007) Mol Vis 13: 273-86 Expression of the cyclin-dependent kinase inhibitor p27Kip1 by developing retinal pigment epithelium. Defoe DM, Levine EM (2003) Gene Expr Patterns 3: 615-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.